Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
278 Leser
Artikel bewerten:
(0)

TEI Biosciences Chairman, President and CEO Yiannis Monovoukas Named Winner of the Ernst & Young Entrepreneur Of The Year 2011 New England Award

BOSTON, June 20, 2011 /PRNewswire/ -- TEI Biosciences Inc. today announced that Yiannis Monovoukas, Ph.D., M.B.A., its Chairman, President and CEO, is the winner of the prestigious Ernst & Young Entrepreneur Of The Year® 2011 New England Award. The program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Dr. Monovoukas was presented with the Ernst & Young Entrepreneur Of The Year® New England 2011 award at the Awards Gala.

In accepting his award, Dr. Monovoukas said, "I feel blessed that my passion for building science-based ventures has resulted in a successful company making innovative medical products that neuro-, general-, trauma-, plastic-, vascular- and orthopedic surgeons use routinely in operating rooms around the world, helping thousands of patients each year. It's a fantastic feeling!"

The Ernst & Young Entrepreneur Of The Year® Program celebrates its 25th anniversary this year and recognizes business leaders in more than 50 countries throughout the world.

About TEI Biosciences Inc.

A Boston-based, privately-held, leading biomedical company, TEI Biosciences has applied its expertise in regenerative medicine to develop and commercialize novel biologic devices for a broad spectrum of soft tissue repair and regeneration applications - from dura, tendon and hernia repair to plastic and reconstructive surgery and wound healing.

TEI sells its products directly and through partnerships with some of the world's major medical device companies. TEI's marketed products include:

  • SurgiMend® and SurgiMend® PRS for plastic & reconstructive surgery, soft tissue reconstruction, hernia repair and muscle flap reinforcement
  • PriMatrix' and PriMatrix' Ag Antimicrobial for skin wound management
  • Durepair® for cranial dura repair (marketed by Medtronic)
  • Xenform' for pelvic floor reconstruction (marketed by Boston Scientific)
  • TissueMend® for tendon augmentation (marketed by Stryker)

About Ernst & Young Entrepreneur Of The Year®

Ernst & Young Entrepreneur Of The Year® is the world's most prestigious business award for entrepreneurs. The award encourages entrepreneurial activity among those with potential, and recognizes the contribution of people who inspire others with their vision, leadership and achievement. The program celebrates those who are building and leading successful, growing, and dynamic businesses.

For more information visit us at www.teibio.com

SOURCE TEI Biosciences Inc.

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.